MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis

MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis

BackgroundDysregulation of the mesenchymal epithelial transition (MET) pathway contributes to poor clinical outcomes in patients with non-small cell lung cancer (NSCLC). Numerous clinical trials are currently investigating several therapies based on modulation of the MET pathway.ObjectivesThis study...

Full description

Bibliographic Details
Main Authors: Linrui Xu, Faping Wang, Fengming Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
MET inhibitors
activity
safety
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1013299/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1013299/full

Similar Items